ONCO-BCG 40MG ING

About

ONCO-BCG 40 MG INJ. VIAL. contains Bacillus Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, utilized as an immunotherapeutic agent. When administered intravesically, BCG induces a localized inflammatory and immune response within the bladder. This response is thought to mediate its anti-tumor effects by activating macrophages, T-lymphocytes, and natural killer cells, which then target and destroy malignant cells in the urothelium. It is primarily indicated for the treatment and prophylaxis of certain types of bladder cancer, particularly non-muscle invasive forms.

The precise mechanism involves the binding of BCG to fibronectin on the bladder wall, followed by internalization into urothelial cells and subsequent immune cell activation. This complex interaction leads to the release of various cytokines and chemokines, creating a robust anti-tumor microenvironment. Its efficacy is well-established in reducing recurrence rates and progression in non-muscle invasive bladder cancer, making it a cornerstone in the management of this disease.

Uses

• Treatment of carcinoma in situ (CIS) of the urinary bladder.
• Prophylaxis of recurrence of superficial papillary tumors of the bladder.
• Adjuvant therapy after transurethral resection of bladder tumors.
• Management of high-grade non-muscle invasive bladder cancer.

Directions For Use

Administered intravesically by a healthcare professional. The specific dose and schedule are determined by the treating physician based on the patient's condition.

Benefits

• Reduces recurrence rates in non-muscle invasive bladder cancer.
• Effective in treating carcinoma in situ of the bladder.
• May prevent progression to more invasive forms of bladder cancer.
• Stimulates a localized immune response against tumor cells.
• Well-established efficacy in its indicated uses.
• Offers a non-surgical treatment option for certain bladder cancers.

Side Effects

• Cystitis (bladder inflammation)
• Urinary frequency and urgency
• Dysuria (painful urination)
• Hematuria (blood in urine)
• Fever and chills
• Malaise and fatigue
• Flu-like symptoms
• Arthralgia (joint pain)
• Nausea and vomiting
• Skin rash
• Granulomatous prostatitis
• BCG sepsis (rare but serious)

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but it's generally advisable to avoid alcohol during cancer treatment to support overall health.
• Pregnancy - Contraindicated in pregnancy due to potential fetal harm. Effective contraception is required for women of childbearing potential.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if BCG is excreted in human milk and could pose a risk to the infant.
• Liver - Use with caution in patients with severe liver impairment, though systemic absorption is minimal. Monitor liver function if systemic symptoms occur.
• Kidney - Use with caution in patients with impaired kidney function, especially if systemic absorption is suspected. Monitor renal parameters.
• Lung - Rarely, systemic BCG infection can lead to pulmonary granulomas. Monitor for respiratory symptoms if systemic dissemination is suspected.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.